Charles River Laboratories International Inc (CRL) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 27 2026 to Jun 28 2025 - CSIMarket
CSIMarket
 


Charles River Laboratories International inc   (NYSE: CRL)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Charles River Laboratories International Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Charles River Laboratories International Inc's ROI in the second quarter of 2026?
Charles River Laboratories International Inc recorded a cumulative net loss of $-236 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -3.61%.

Within the Healthcare sector 204 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2687 to 2755.

Definition and Formula of Return on Investment



Return On Investment (Jun 27 2026)
II. Quarter
(Mar 28 2026)
I. Quarter
(Dec 27 2025)
IV. Quarter
(Sep 27 2025)
III. Quarter
(Jun 28 2025)
II. Quarter
Y / Y Investment Change TTM -3.29 % -2.89 % -4.53 % -5.78 % -3.2 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 6,397 6,831 6,309 6,630 6,748
Return On Investment (TTM) -3.61 % -2.76 % -2.15 % -1.19 % -0.96 %
CRL's Overall Ranking # 2755 # 2687 # 2462 # 1970 # 2113
Seq. Investment Change TTM -1.32 % 0.19 % -0.84 % -1.34 % -0.92 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -236 -183 -142 -80 -65




Return On Investment CRL's Ranking
Within: No.
Industry # 10
Sector # 205
Overall # 2755

Return On Investment Statistics
High Average Low
9.15 %
4.34 %
-19.16 %
(Mar 26 2016)   (Jun 25 2011)







Financial Statements
Charles River Laboratories International Inc's II. Quarter Investments $ 6,397 Millions CRL's Balance sheet
Charles River Laboratories International Inc's II. Quarter Income $ -1 Millions Quarterly CRL's Income Statement
CRL's Income by Division See CRL's Income by Division


CRL Annual Return On Investment (Dec 27 2025)
2025
(Dec 28 2024)
2024
(Dec 30 2023)
2023
(Dec 31 2022)
2022
(Dec 25 2021)
2021
Total Investments in Millions 6,015 6,534 7,140 6,511 5,991
Y / Y Investment Growth -7.94 % -8.48 % 9.66 % 8.68 % 28.81 %
Net Income in Millions -142 25 480 493 399
Y / Y Net Income Growth - -94.74 % -2.48 % 23.51 % 9.18 %
Annual Return On Investment -2.36 % 0.39 % 6.73 % 7.57 % 6.66 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CRL's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CRL's Competitors
Subscribers only: Roi for Charles River Laboratories International Inc's Suppliers
Subscribers only: Return On Investment for CRL's Customers

Other Ratios
CRL's Roa CRL's Inventory Turnover Ratio CRL's Growth Rates CRL's Dividend Statistics
CRL's Profitability Ratios CRL's Asset Turnover Ratio CRL's Dividend Growth
CRL's Roe CRL's Valuation Ratios CRL's Financial Strength Ratios CRL's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 27 2026, within Healthcare Sector ROI


Date modified: 2026-09-26T06:58:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.